See every side of every news story
Published loading...Updated

Ten projects in the areas of HIV, hepatitis and breast cancer receive 300 thousand euros

Summary by Noticias Ao Minuto
As announced today by the biopharmaceutical company Gilead Sciences, in this edition, five research projects and five community projects were selected in the areas of HIV (human immunodeficiency virus that causes AIDS), chronic viral hepatitis and breast cancer, from a group of 47 submitted by NHS entities, academic and scientific institutions, and non-governmental organizations. The Gilead Genesis program, which is highly sponsored by the Presi…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Noticias ao Minuto broke the news in Portugal on Tuesday, February 11, 2025.
Sources are mostly out of (0)